ANI Pharmaceuticals
ANIP
#5213
Rank
ยฃ0.94 B
Marketcap
ยฃ44.83
Share price
-3.96%
Change (1 day)
8.60%
Change (1 year)

Revenue for ANI Pharmaceuticals (ANIP)

Revenue in 2024 (TTM): ยฃ0.42 Billion

According to ANI Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ0.42 Billion. In 2023 the company made a revenue of ยฃ0.38 Billion an increase over the revenue in the year 2022 that were of ยฃ0.26 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ANI Pharmaceuticals from 2000 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.42 B12.37%
2023 ยฃ0.38 B46.11%
2022 ยฃ0.26 B63.33%
2021 ยฃ0.16 B4.69%
2020 ยฃ0.15 B-2.9%
2019 ยฃ0.15 B-0.81%
2018 ยฃ0.15 B21.36%
2017 ยฃ0.13 B25.53%
2016 ยฃ0.10 B102.4%
2015 ยฃ51.5 M43.26%
2014 ยฃ35.94 M140.41%
2013 ยฃ14.95 M950.47%
2012 ยฃ1.42 M408.43%
2011 ยฃ0.27 M-82.53%
2010 ยฃ1.6 M106.16%
2009 ยฃ0.77 M-69.72%
2008 ยฃ2.56 M934.63%
2007 ยฃ0.24 M-96.63%
2006 ยฃ7.37 M4820.27%
2005 ยฃ0.14 M269.28%
2004 ยฃ0.04 M
2001 ยฃ1.24 M2909.53%
2000 ยฃ0.04 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ3.09 B 625.46%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ยฃ5.96 M-98.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ12.90 B 2,922.53%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
ยฃ44.08 B 10,224.09%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.24 B-42.36%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ6.57 M-98.46%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ179.72 B 41,986.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ39.57 B 9,166.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ1.77 B 315.18%๐Ÿ‡ฌ๐Ÿ‡ง UK